Pyrazole p38 map kinase inhibitors
US9771354B2 · kind B2 · utility
1Cited by
0References
31Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 18, 2016 |
| Grant date | Sep 26, 2017 |
| Priority date | — |
| Expiry date | Jan 18, 2036 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D401/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
There are provided inter alia compounds of formula (I)wherein R1, R2a, R2b, R3, R4, L, X, R5 and R6 are as defined in the description for use in the treatment of inflammatory diseases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.